Reference of 176706-98-2, Because a catalyst decreases the height of the energy barrier, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.176706-98-2, Name is 2,2-Bis[(4S)-4-benzyl-2-oxazolin-2-yl]propane, molecular formula is C23H26N2O2. In a article，once mentioned of 176706-98-2
The first examples of asymmetric copper-catalysed intramolecular C-H insertion reactions of 2-sulfonyl-2-diazoacetamides are described; trans gamma-lactams with up to 82% ee are achieved with the CuCl2-bisoxazoline-NaBARF catalyst system. The reactions generally display high efficiency and high trans selectivity, and also a strong regiochemical preference for insertion to lead to the formation of 5-membered rings over 4-membered rings. In cases where there are competing C-H insertion pathways available, to form sulfolanes or thiopyrans, only the insertion into the amide chain to form gamma-lactams is observed. With phenylsulfonyl derivatives, a minor competing C-H insertion pathway leading to beta-lactams is seen; interestingly, changing the identity of the copper ligand changes the product ratio of beta/gamma-lactams. The copper catalysed reactions compare favorably in terms of efficiency and enantioselectivity to the corresponding reactions catalysed by commercially available chiral rhodium catalysts.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 176706-98-2, and how the biochemistry of the body works.Reference of 176706-98-2
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI